Chronic hepatitis C and superimposed nonalcoholic fatty liver disease. - Wikidata - awgldk - TriplyDB

Chronic hepatitis C and superimposed nonalcoholic fatty liver disease.

Chronic hepatitis C and superimposed nonalcoholic fatty liver disease.

http://www.wikidata.org/entity/Q34308953

about

NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations Hepatitis C Virus, Insulin Resistance, and Steatosis Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen Managing chronic hepatitis C in the difficult-to-treat patient Natural history of chronic hepatitis C Importance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitization Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network Histopathology of nonalcoholic fatty liver disease.Central portalization correlates with fibrosis but not with risk factors for nonalcoholic steatohepatitis in steatotic chronic hepatitis C.Fibrosis and disease progression in hepatitis C.Non-alcoholic fatty liver disease: an overview.Correlation of serum leptin levels with anthropometric and metabolic parameters and biochemical liver function in Chinese patients with chronic hepatitis C virus infection.Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.Hepatitis C virus-induced hepatocellular steatosis.Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey.Review article: non-alcoholic fatty liver disease and hepatitis C--risk factors and clinical implications.Review article: chronic hepatitis C--natural history and cofactors.Microarray technology in the study of obesity and non-alcoholic fatty liver disease.Hepatitis C and steatosis: a reappraisal.Histological assessment of non-alcoholic fatty liver disease.Status of essential trace minerals and oxidative stress in viral hepatitis C patients with nonalcoholic fatty liver disease Clinical expression of insulin resistance in hepatitis C and B virus-related chronic hepatitis: differences and similarities.Role of liver biopsy in nonalcoholic fatty liver disease.Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review.Should adults with diabetes mellitus be vaccinated against hepatitis B virus? A systematic review of diabetes mellitus and the progression of hepatitis B disease.Severity of liver disease among chronic hepatitis C patients: an observational study of 4594 patients in five European countries.Outcome, tolerability and compliance of compassionate use interferon and ribavirin for hepatitis C infection in a shared care hospital clinic.Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.Factors associated with the presence of nonalcoholic steatohepatitis in patients with chronic hepatitis C.Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis.Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis.Hepatic steatosis in chronic hepatitis C: impact on response to anti-viral treatment with peg-interferon and ribavirin.Studies of anticancer drug cytotoxicity based on long-term HepG2 spheroid culture in a microfluidic system.Nonalcoholic fatty liver disease and the ongoing role of liver biopsy evaluation.

P2860

Q26745576-D1FEB07E-6CA3-43E4-8AE1-3212C46E8000 Q26751755-6982DF64-806F-4AE1-8FE6-78B1DC37A80E Q26861095-3F386CE2-57A7-4F4D-B617-3D1143DEF02A Q27490409-EDC9F43E-8354-4FCA-A2B5-48ECF97A7A72 Q29620673-A0AA595E-529F-4735-9394-EDABDAC90A26 Q33812148-E4831A89-5711-48C0-9FE8-1CF2052D16DB Q34085058-B2560EB2-55D6-4A2C-8B9A-7F73A0001CE0 Q34306736-4B091A5E-0C3A-4339-AE62-8808C093BC48 Q34698082-73EFF7E7-2F47-4CF7-8F94-A561B0B3B95A Q34984040-598A0585-8DED-4D14-8529-9F11E24B3819 Q35009628-5505B94A-4CEE-4A51-8A6C-81D641D50739 Q35045338-284A68A3-CC48-4B08-B910-22A8F09E4825 Q35598407-19D34AA9-B162-4A9D-9C71-49AE90D1144D Q36060022-3CD6E72C-8E87-449E-A3EC-06E81EC85ECE Q36178491-A4AD4F41-02E7-4439-B611-222BD798911D Q36286313-670F0140-226A-4ED8-8BEA-DCED77C4841F Q36286336-95E97156-2D83-4A72-8384-E1A508E10F90 Q36338671-3B81019F-D5F1-44D6-BEBB-5870CC58D538 Q36377276-AD8B9860-32DB-4DD0-A6C0-304C20DC1638 Q36634377-5A7A9681-F2DE-4563-A3C7-592AFC31FA25 Q36800914-648A4706-9F6F-49DA-8114-2FA325ED2706 Q37122348-6FAE7415-203B-4C9F-A850-2859B51796F5 Q38235945-322002E1-D0C9-40F5-958A-B27F06F220CE Q38542209-25B8FEC8-972B-4280-A9F0-9EF3E658B77A Q38662073-9CA2F999-1231-451F-9798-B6DE7A49EA6F Q39149337-6CB96C8C-8BBA-4F4F-89DA-06F3F33F0B89 Q42614732-6F438133-3F5E-4417-B4AA-1944DC59A9BF Q42978401-7AD373DD-B876-4D04-A9B7-6339E0A848C8 Q42991971-6EC38E13-06DF-46F2-B211-B9F0D715E52D Q42999758-69C8744E-61AF-436C-9DEA-FFF2E159A223 Q46515459-D564C08E-5EC9-4326-96CD-24A29BF2B230 Q46789982-5CC98EA1-EFD1-45D3-8122-2B3121CBB90F Q51446342-13B54A71-80A6-4389-9441-E0168C2AEDC2 Q55122484-5BA5111F-4C10-496C-8DDB-DFED34B51175

P2860

Chronic hepatitis C and superimposed nonalcoholic fatty liver disease.

http://www.wikidata.org/entity/Q34308953

description

2001 nî lūn-bûn

@nan

2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Chronic hepatitis C and superimposed nonalcoholic fatty liver disease.

@ast

Chronic hepatitis C and superimposed nonalcoholic fatty liver disease.

@en

Chronic hepatitis C and superimposed nonalcoholic fatty liver disease.

@nl

type

label

Chronic hepatitis C and superimposed nonalcoholic fatty liver disease.

@ast

Chronic hepatitis C and superimposed nonalcoholic fatty liver disease.

@en

Chronic hepatitis C and superimposed nonalcoholic fatty liver disease.

@nl

prefLabel

Chronic hepatitis C and superimposed nonalcoholic fatty liver disease.

@ast

Chronic hepatitis C and superimposed nonalcoholic fatty liver disease.

@en

Chronic hepatitis C and superimposed nonalcoholic fatty liver disease.

@nl

P1433

Q34308953-05618EF2-2B68-453C-A7A2-E3B3805B8769

P1476

Q34308953-84FAB5F7-A74B-49F1-AEB1-29686B693FF6

P2093

Q34308953-19A2EA71-165D-4C2F-B8D6-9DC4D954AE37

Q34308953-4B87C1E5-ED7F-496C-AED2-D1B46692DCB0

Q34308953-696B2469-3D5A-482D-B161-9324948AA7B1

Q34308953-92774FC2-AC08-43A2-B53A-61C00C57DA50

Q34308953-C9ECB72A-A251-48F6-AFB3-7D364600A271

Q34308953-CCAD1AB7-263C-4EE6-9AA0-481DACDAC738

P2860

Q34308953-01C20560-2168-4621-B5DD-60156BC5342A

Q34308953-2620407D-D55D-4784-9BB8-DEBB2E41912E

Q34308953-28F4AF8D-E9CA-4E00-946B-A0AC0068DA7E

Q34308953-2C3C0142-4E98-4D2F-80AC-74F9DA345C3E

Q34308953-36F26FB0-64D4-4E63-93E9-CA78659B6493

Q34308953-401ACEA9-C914-4B6D-9D13-5ADB44D1C782

Q34308953-4E512E58-BA57-49C2-85D1-3F0DF59D7639

Q34308953-F185F3C9-17C4-4573-8959-685D3751136C

P304

Q34308953-240427C7-2084-4A4F-9252-9D4CAB3DEF0D

P31

Q34308953-8FC01068-D7A1-491B-B4BF-A91D076B1DFA

P356

Q34308953-B6963A14-A38B-4C03-B497-7F8D0985DE5F

P433

Q34308953-DC6FAC60-38C5-4604-AEA7-926DA601A3C6

P478

Q34308953-78241C90-7BDA-4CCB-8F52-3FBEBB112C39

P577

Q34308953-28623202-6CA4-48EB-958A-FD52389A00A0

P698

Q34308953-1FCF1691-39A8-40FE-819E-DFCA597BBC27

P356

J.1600-0676.2001.021004266.X

P1433

P1476

Chronic hepatitis C and superimposed nonalcoholic fatty liver disease.

@en

P2093

Boparai N

http://www.w3.org/2001/XMLSchema#string

Gramlich T

http://www.w3.org/2001/XMLSchema#string

Olano A

http://www.w3.org/2001/XMLSchema#string

Ong JP

http://www.w3.org/2001/XMLSchema#string

Speer C

http://www.w3.org/2001/XMLSchema#string

Younossi ZM

http://www.w3.org/2001/XMLSchema#string

P2860

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

Histological grading and staging of chronic hepatitis

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

Hepatitis C: an update on the silent epidemic.

The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses.

Diabetes mellitus as a risk factor of liver cirrhosis in patients with chronic hepatitis B virus infection.

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.

P304

266-271

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1034/J.1600-0676.2001.021004266.X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2001-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11454190

http://www.w3.org/2001/XMLSchema#string